Recently, Bernau and colleagues [43] further showed the efficacy of selective inhibition of the BRD4 BD1 domain in reducing myofibroblast differentiation and reversing established pulmonary fibrosis in mice using the BRD4 BD1-selective inhibitor ZL0591. Here, BRD4 is linked to pulmonary fibrosis.